Vietnam Health Ministry Says Drug Price Freeze To Continue
This article was originally published in PharmAsia News
Executive Summary
Vietnam plans to extend its freeze on pharmaceutical prices beyond the current June 30 expiration date, the Ministry of Health says. In fact, the ministry says any domestic or foreign drug maker who raises prices before June 30 will be fined and closed temporarily. Companies have argued the price of imported materials they use to make their drugs requires them to charge more, sometimes just to break even. The price freeze is in the form of a requirement that local agencies not consider any applications for price increases until June 30, leading many companies to reduce production. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.